Hans-Peter Anton Knopf

Sarsia Venture Management AS (SVM) is a venture capital advisory and management firm based in Bergen, Norway. They manage and advise the Sarsia Life Science Fund, established in 2005, which focuses on life science and biotechnology opportunities in the Nordic region.

Balter Medical AS engages in the development and commercialization of biomedical technology. Its product assists healthcare professionals in diagnosing patients with Melanoma. The company was founded by Jakob Johan Stamnes and Knut Stamnes on December 13, 2000 and is headquartered in Bergen, Norway.

DCC Healthcare Ltd. supplies medical, surgical, and laboratory equipment and pharmaceuticals to the Irish healthcare sector. The company is headquartered in Stillorgan, Ireland.

Aenova Holding GmbH provides supplies to the pharmaceutical and healthcare industries. The firm develops, produces, and markets solid dosage products such as soft and hard capsules, tablets, film-coated tablets, and effervescent tablets. Its services include production, supply chain management, packaging, support and analytics. The company was founded in 2008 and is headquartered in Starnberg, Germany.

Eli Lilly Norge AS engages in the provision of pharmaceutical products and services. Its commodities were developed for the treatment of diabetes, cardiovascular diseases, cancer, nervous system, osteoporosis, psoriasis, rheumatology, urology, and growth failure. The company was founded in 1976 and is headquartered in Oslo, Norway.

Catalent Pharma Solutions Ltd. develops and markets drug delivery systems. The company is headquartered in Swindon, GB.

The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom.

Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom.

ScreenCancer AS offers cancer screening and diagnostic program to the public. It provides a panel of screening tests for several major cancers such as colorectal, bladder, breast, prostate, skin, and lung. The company was founded by Christian Horn and Dagfinn Steinar Ogreid in 2007 and is headquartered in Sola, Norway.

ExpreS2ion Biotechnologies ApS operates as a biotechnology company which engages in the field of protein production in Drosophila Schneider-2 cells. Its services include custom proteins and research & development reagents, process development, and feasibility studies. The company was founded by Charlotte Dyring, Martin Roland Jensen, and Willem Adriaan de Jongh in 2009 and is headquartered in Horsholm, Denmark.

Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland.

Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway.

APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway.

Zelluna Immunotherapy AS engages in research and development on biotechnology. The company is headquartered in Oslo, Norway.

Novel Diagnostics AS provides biomedical research and diagnostics development services. It sells and develops medical and diagnostic products and drives commercialization of research results. The firm also invests in securities; either in form of follow-up investments in companies already has invested in, or as part of other strategic investments. The company was founded on June 10, 2002 and is headquartered in Bergen, Norway.

Epsis AS is a holding company that specializes in development and sales of its software Epsis TeamBox. Its product is a collaboration management software solution designed to facilitate meeting workflows and sharing of information, enabling "real-time" decision making in a collaborative environment. The company was founded on June 27, 2001 and is headquartered in Kokstad, Norway.

Gundersen & Moldestad AS is a Norwegian company that retails hardware and wholesales plumbing supplies, heating equipment, and hardware. The private company is based in Laksevåg, Norway.

The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010.